Literature DB >> 17257782

Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.

Robert K Brooner1, Michael S Kidorf, Van L King, Kenneth B Stoller, Karin J Neufeld, Ken Kolodner.   

Abstract

This 6-month randomized clinical trial (with 3-month follow-up) used a 2x2 design to compare the independent and combined effectiveness of two interventions designed to improve outcomes in treatment-seeking opioid dependent patients (n=236): motivated stepped care (MSC) and contingent voucher incentives (CVI). MSC is an adaptive treatment strategy that uses principles of negative reinforcement and avoidance to motivate both attendance to varying levels of counseling services and brief periods of abstinence [Brooner, R.K., Kidorf, M., 2002. Using behavioral reinforcement to improve methadone treatment participation. Sci. Pract. Perspect. 1, 38-46; Brooner, R.K., Kidorf, M.S., King, V.L., Peirce, J.M., Bigelow, G.E., Kolodner, K., 2004. A modified "stepped care" approach to improve attendance behavior in treatment seeking opioid abusers. J. Subst. Abuse Treat. 27, 223-232]. In contrast, CVI [Higgins, S., Delaney, D.D., Budney, A.J., Bickel, W.K., Hughes, J.R., Foerg, B.A., Fenwick, J.W., 1991. A behavioral approach to achieving initial cocaine abstinence. Am. Psychiatr. 148, 1218-1224] relies on positive reinforcement to motivate drug abstinence. The results showed that the combined approach (MSC+CVI) was associated with the highest proportion of drug-negative urine samples during both the randomized and 3-month follow-up arms of the evaluation. The CVI-only and the MSC-only conditions evidenced similar proportions of drug-negative urine samples that were both significantly greater than the standard care (SC) comparison group. Voucher-based reinforcement was associated with better retention, while adaptive stepped-based care was associated with better adherence to scheduled counseling sessions. These results suggest that both CVI and MSC are more effective than routine care for reducing drug use in opioid dependent outpatients, and that the overall benefits of MSC are enhanced further by adding positive reinforcement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257782      PMCID: PMC1948819          DOI: 10.1016/j.drugalcdep.2006.12.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  41 in total

1.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

2.  Marginal Mean Models for Dynamic Regimes.

Authors:  S A Murphy; M J van der Laan; J M Robins
Journal:  J Am Stat Assoc       Date:  2001-12-01       Impact factor: 5.033

3.  Drug abuse treatment retention and process effects on follow-up outcomes.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

4.  On the use of concordant pairs in matched case-control studies.

Authors:  K Y Liang; S L Zeger
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

5.  Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure.

Authors:  M Kidorf; M L Stitzer; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1995-10       Impact factor: 4.492

6.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

7.  Behavioral contingencies improve counseling attendance in an adaptive treatment model.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Jessica M Peirce; George E Bigelow; Ken Kolodner
Journal:  J Subst Abuse Treat       Date:  2004-10

8.  One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment.

Authors:  K M Carroll; C Nich; S A Ball; E McCance; T L Frankforter; B J Rounsaville
Journal:  Addiction       Date:  2000-09       Impact factor: 6.526

Review 9.  Stepped care treatment for eating disorders.

Authors:  G T Wilson; K M Vitousek; K L Loeb
Journal:  J Consult Clin Psychol       Date:  2000-08

10.  Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.

Authors:  B J Rounsaville; T R Kosten; M M Weissman; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-08
View more
  22 in total

1.  Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.

Authors:  Andjela Baewert; Reinhold Jagsch; Bernadette Winklbaur; Gerda Kaiser; Kenneth Thau; Annemarie Unger; Constantin Aschauer; Manfred Weninger; Verena Metz
Journal:  Eur Addict Res       Date:  2012-02-21       Impact factor: 3.015

2.  Adaptive Interventions in Drug Court: A Pilot Experiment.

Authors:  Douglas B Marlowe; David S Festinger; Patricia L Arabia; Karen L Dugosh; Kathleen M Benasutti; Jason R Croft; James R McKay
Journal:  Crim Justice Rev       Date:  2008

Review 3.  Personalized treatment of alcohol dependence.

Authors:  Henry R Kranzler; James R McKay
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

4.  Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting.

Authors:  C Patrick Carroll; Michael Kidorf; Eric C Strain; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-04-02

5.  Presence of Drug-Free Family and Friends in the Personal Social Networks of People Receiving Treatment for Opioid Use Disorder.

Authors:  Michael Kidorf; Carl Latkin; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2016-08-24

Review 6.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

7.  Using enhanced and integrated services to improve response to standard methadone treatment: changing the clinical infrastructure of treatment networks.

Authors:  Karin Neufeld; Michael Kidorf; Van King; Ken Stoller; Michael Clark; Jessica Peirce; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2009-08-29

8.  Adaptive interventions may optimize outcomes in drug courts: a pilot study.

Authors:  Douglas B Marlowe; David S Festinger; Patricia L Arabia; Karen L Dugosh; Kathleen M Benasutti; Jason R Croft
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

9.  Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial.

Authors:  Michael Kidorf; Robert K Brooner; Neeraj Gandotra; Denis Antoine; Van L King; Jessica Peirce; Sharon Ghazarian
Journal:  Drug Alcohol Depend       Date:  2013-07-15       Impact factor: 4.492

10.  Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.

Authors:  Mohit P Chopra; Reid D Landes; Kirstin M Gatchalian; Lisa C Jackson; August R Buchhalter; Maxine L Stitzer; Lisa A Marsch; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.